Advertisement

Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center

Published:December 29, 2022DOI:https://doi.org/10.1016/j.thromres.2022.12.018
      Clinical practice guidelines recommend management of acute pulmonary embolism (PE) based on early risk stratification. Gaps in the literature and a growing number of therapeutic options have prompted integration of multidisciplinary PE response teams, which merge expertise of various disciplines to individualize care, based on patient risk profile and comorbidities [
      • Provias T.
      • Dudzinski D.M.
      • Jaff M.R.
      • Rosenfield K.
      • Channick R.
      • Baker J.
      • Weinberg I.
      • Donaldson C.
      • Narayan R.
      • Rassi A.N.
      • Kabrhel C.
      The Massachusetts General Hospital pulmonary embolism response team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.
      ].
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Provias T.
        • Dudzinski D.M.
        • Jaff M.R.
        • Rosenfield K.
        • Channick R.
        • Baker J.
        • Weinberg I.
        • Donaldson C.
        • Narayan R.
        • Rassi A.N.
        • Kabrhel C.
        The Massachusetts General Hospital pulmonary embolism response team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism.
        Hosp. Pract. 1995; 2014: 31-37
        • Konstantinides S.V.
        • Torbicki A.
        • Agnelli G.
        • Danchin N.
        • Fitzmaurice D.
        • Galie N.
        • Gibbs J.S.
        • Huisman M.V.
        • Humbert M.
        • Kucher N.
        • Lang I.
        • Lankeit M.
        • Lekakis J.
        • Maack C.
        • Mayer E.
        • Meneveau N.
        • Perrier A.
        • Pruszczyk P.
        • Rasmussen L.H.
        • Schindler T.H.
        • Svitil P.
        • Vonk Noordegraaf A.
        • Zamorano J.L.
        • Zompatori M.
        • Task Force for the D and Management of Acute Pulmonary Embolism of the European Society of C
        2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.
        European heart journal. 2014; 35 (3069a-3069k): 3033-3069
        • Jimenez D.
        • Bikdeli B.
        • Barrios D.
        • Morillo R.
        • Nieto R.
        • Guerassimova I.
        • Muriel A.
        • Jara-Palomares L.
        • Moores L.
        • Tapson V.
        • Yusen R.D.
        • Monreal M.
        • investigators R
        Management appropriateness and outcomes of patients with acute pulmonary embolism.
        Eur. Respir J. 2018; : 51
        • Chopard R.
        • Piazza G.
        • Falvo N.
        • Ecarnot F.
        • Besutti M.
        • Capellier G.
        • Schiele F.
        • Badoz M.
        • Meneveau N.
        An original risk score to predict early major bleeding in acute pulmonary embolism: the syncope, anemia, renal dysfunction (PE-SARD) bleeding score.
        Chest. 2021; 160: 1832-1843
        • Marti C.
        • John G.
        • Konstantinides S.
        • Combescure C.
        • Sanchez O.
        • Lankeit M.
        • Meyer G.
        • Perrier A.
        Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.
        Eur. Heart J. 2015; 36: 605-614
        • Keller K.
        • Hobohm L.
        • Ebner M.
        • Kresoja K.P.
        • Munzel T.
        • Konstantinides S.V.
        • Lankeit M.
        Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.
        Eur. Heart J. 2020; 41: 522-529
        • Meyer G.
        • Vicaut E.
        • Danays T.
        • Agnelli G.
        • Becattini C.
        • Beyer-Westendorf J.
        • Bluhmki E.
        • Bouvaist H.
        • Brenner B.
        • Couturaud F.
        • Dellas C.
        • Empen K.
        • Franca A.
        • Galie N.
        • Geibel A.
        • Goldhaber S.Z.
        • Jimenez D.
        • Kozak M.
        • Kupatt C.
        • Kucher N.
        • Lang I.M.
        • Lankeit M.
        • Meneveau N.
        • Pacouret G.
        • Palazzini M.
        • Petris A.
        • Pruszczyk P.
        • Rugolotto M.
        • Salvi A.
        • Schellong S.
        • Sebbane M.
        • Sobkowicz B.
        • Stefanovic B.S.
        • Thiele H.
        • Torbicki A.
        • Verschuren F.
        • Konstantinides S.V.
        • Investigators P.
        Fibrinolysis for patients with intermediate-risk pulmonary embolism.
        N. Engl. J. Med. 2014; 370: 1402-1411
        • Smythe M.A.
        • Priziola J.
        • Dobesh P.P.
        • Wirth D.
        • Cuker A.
        • Wittkowsky A.K.
        Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.
        J. Thromb. Thrombolysis. 2016; 41: 165-186
        • Kiser T.H.
        • Burnham E.L.
        • Clark B.
        • Ho P.M.
        • Allen R.R.
        • Moss M.
        • Vandivier R.W.
        Half-dose versus full-dose alteplase for treatment of pulmonary embolism.
        Crit. Care Med. 2018; 46: 1617-1625
        • van Es N.
        • Coppens M.
        • Schulman S.
        • Middeldorp S.
        • Buller H.R.
        Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.
        Blood. 2014; 124: 1968-1975